The Wizard Of Oz – There’s No Place Like Ophthalmology

The Wizard Of Oz - There's No Place Like Ophthalmology

Date: 16/05/2025 (AEST)

Venue: Stranger's Function Room, Parliament House, 6 Macquarie St, Sydney, NSW, 2000

Provider: Sydney Retina Clinic & Day Surgery

Contact: Giulia Moretti, [E] giulia.moretti@acurio.com.au, [P] 02 9221 3755

Activity Outline

Wizard of Oz, Optometrist Seminar

Calling all witches and wizards! You are invited to join a magical optom gathering. Join us at Stranger's Room, Parliament House. 

RSVP to Giulia by 23rd of April. 

Learning Objectives

• Identify the types of systemic drugs commonly associated with macular complications
• Define macular complications and their connection to systemic drug use
• Explain how systemic drugs affect the macula and discuss the pathways leading to macular complications
• Outline the symptoms and clinical signs of macular complications
• Highlight risk factors including drug dosage, duration of use and pre-existing conditions
• Discuss strategies to manage macular complications
• Identify the risk factors associated with normal tension glaucoma
• Explain the potential causes and contributing factors to normal and low tension glaucoma
• Describe the clinical features of normal and low tension glaucoma
• Outline the diagnostic methods for normal and low tension glaucoma
• Discuss treatment options for normal and low tension glaucoma
• Understand the purpose and function of the optic nerve
• Identify common diseases affecting the optic nerve
• Explain the way in which certain diseases of the optic nerve can affect the patient’s vision
• Describe how these diseases can be identified, diagnosed and differentiated
• Describe the treatment options available for optic nerve diseases
• Explain proliferative diabetic retinopathy and its progression
• Discuss how pregnancy influences diabetes management and the progression of PDR
• Identify risk factors for PDR progression during pregnancy
• Discuss strategies for managing diabetes and PDR during pregnancy
• Outline the safety and considerations of treatments like anti-VEGF injections during pregnancy
• Describe the effect of high dose Eylea on patient vision outcomes
• Explain how HD Eylea differs from the standard dose in terms of concentration, administration, and patient outcomes
• Outline the recommended treatment protocol for patients starting treatment with high dose Eylea
• Discuss the rationale for using a higher dose in specific patient populations
• Describe the effect of an increased treatment interval on patient compliance
• Describe how HD Eylea works to inhibit VEGF and reduce retinal vascular leakage
• Understand the risks and complications of vitrectomy surgery
• Identify the possible causes for endophthalmitis, dropped lens and choroidal haemorrhage
• Describe the signs and symptoms of endophthalmitis, dropped lens and choroidal haemorrhage
• Outline the surgical interventions necessary to treat endophthalmitis, dropped lens and choroidal haemorrhage
• Explain the importance of timely intervention to prevent further complications
• Discuss strategies to minimize risks during and after surgery
• Identify the current clinical trials that are being conducted
• Describe the medical conditions that are eligible for clinical trials
• Outline the recent results of clinical trials and the effectiveness of the medication
• Explain how the results from trials will be applied to real world patient scenarios

Max CPD hours awarded: 3

Session Information